<DOC>
	<DOCNO>NCT02837367</DOCNO>
	<brief_summary>The NutriGen project use nutrigenomic method determine effectiveness treatment specific dietary food , basis genetic risk predisposition ( genetic signature ) obese individual .</brief_summary>
	<brief_title>Use Nutrigenomic Models Personalized Treatment With Medical Foods Obese People</brief_title>
	<detailed_description>NutriGen project specific aim 1 . Establishing genetic signature model , involve donation methyl group unsaturated omega-6/3 fatty acid metabolism , high predictive value classification dyslipidemia insulin resistance obese subject . 1 . Establishing genetic signature model obese adult dyslipidemia . 2 . Establishing genetic signature model obese child insulin resistance . c. Establishing correlation blood/plasma concentration relevant metabolite , genetic signature dyslipidemia profile adult , respectively profile insulin resistance obese child . NutriGen project specific aim 2 . Determining efficacy dietary food specific treatment , also correlate genetic signature ( nutrigenomics ) , base correlation define objective 1 : 1 . Implementation treatment dietary food ( adult ) , presence/absence already prescribed treatment ; 2 . Implementation treatment dietary food ( child ) , presence/absence already prescribed treatment .</detailed_description>
	<mesh_term>Dyslipidemias</mesh_term>
	<criteria>Adults : 18 70 year old ; obesity present define body mass index ( BMI ) ≥30 kg/m2 abdominal circumference ≥84 cm ( woman ) , ≥90 cm ( men ) ; dyslipidemia present define : serum Cholesterol ≥200 mg/dl , HDLc ≤50 mg/dl ( woman ) ≤40 mg/dl ( men ) , serum Triglycerides ≥150 mg/dl , present treatment dyslipidemia ( e.g . statin , fibrates , omega3 fatty acid , cholestyramine , ezetimibe ) . Children : age 7 18 year old ; BMI &gt; +2SD WHO reference Adults : diagnose type cancer , medical history cancer ; autoimmune disease ; psychiatric disorder ; blood coagulation disorder ; history drug abuse ; alcohol abuse evaluate use AUDITC . Children : exclusion criterion adult ; familial hypercholesterolemia ; endocrineinduced obesity ( Cushing syndrome , hypothyroidism , growth hormone deficit ) , hypothalamusinduced obesity ( BabinskiFröhlich syndrome ) , genetic syndrome ( PraderWilli , achondroplasia , BardetBiedl , Fanconi , Turner , etc . ) ; deposition disease ( glycogenosis , lipomatosis ) ; personal history : convulsive disorder , nephrotic syndrome , asthma necessitated corticoid treatment .</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>nutrigenetics</keyword>
	<keyword>medical food</keyword>
	<keyword>obesity</keyword>
	<keyword>child</keyword>
	<keyword>adult</keyword>
</DOC>